Application of radix astragali and radix angelicae sinensis blood replenishing decoction and radix astragali and radix angelicae sinensis alcohol extract in body whitening
Through the application of Astragalus Angelica Buxue Decoction and Alcohol Extract, the production and oxidative stress of melanin are inhibited, and the application of traditional Chinese medicine beauty theory in the modern beauty industry is solved, and the significant effect of skin whitening is achieved, and new for traditional Chinese medicine cosmetics are provided. R&D direction.
Patent Information
- Application Number
- CN202411126855.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-26
AI Technical Summary
In the field of traditional Chinese medicine beauty, it is difficult for the existing technology to effectively apply traditional Chinese medicine prescriptions to nourish Qi and promote blood circulation to modern beauty industries, especially in skin color whitening, lacking systematic theoretical basis and experimental basis, and the traditional Chinese medicine cosmetics market is sluggish, lacking clear definition and theoretical support. .
Astragalus Angelica Buxue Decoction and Astragalus Angelica Alcohol Extract are used to inhibit the activities of MTYR monophenolase and bisphenolase, eliminate DPPH and ABTS free radicals, improve SOD activity, reduce MDA production, and inhibit ROS generation, thereby achieving the body's whitening effect.
Astragalus Angelica extract has significant whitening effects, can inhibit melanin production from the source, and has the potential to develop into a new whitening cosmetic product. Through the synergy between domestic and external use, it provides experimental support and new ideas for Chinese medicine beauty.
Smart Images

Figure CN119015186A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to application of astragalus and angelica blood-replenishing soup and astragalus and angelica alcohol extract in body whitening. Background Art
[0002] In the past, when people mentioned skin care concepts such as whitening and anti-aging, most of them usually thought of various external skin care products and makeup products. With the continuous improvement of the quality of life and the upgrading of health concepts, women's beauty consumption has gradually tended to "internal adjustment and external care" to achieve daily appearance management. "Makeup and food are of the same origin" is a concept derived from "medicine and food are of the same origin". In the cosmetics field, it means using natural, healthy and safe food-grade raw materials to make cosmetics, while in the food field, it means applying popular, high-potential, natural and safe cosmetic raw materials to food to create functional foods that can achieve oral beauty care, thereby transforming the skin care method from outside to inside. Although the cross-border new cosmetic raw materials of oral ingredients are indeed a new development idea, there are still many challenges and difficulties.
[0003] In fact, the concepts of "internal regulation and external nourishment" and "using the inside to nourish the outside" coincide with the holistic view in TCM theory. "What is inside must be reflected outside", and the skin is a mirror that reflects the functions of the human body's internal organs, qi and blood, and meridians. As stated in the Yellow Emperor's Classic of Internal Medicine, "the twelve meridians and three hundred and sixty-five collaterals, all of which are on the face and run through the empty orifices." TCM theory believes that dysfunction of the liver, spleen, and kidneys leads to symptoms such as qi stagnation and blood stasis, which prevents qi and blood from nourishing the face, and the face is not nourished, resulting in disfiguring diseases. Therefore, promoting blood circulation and removing blood stasis, and replenishing qi and blood are the basis of beauty, and are also the guiding ideology of TCM beauty. For internal use, TCM beauty has a long history and has accumulated thousands of years of experience. Various qi and blood tonic prescriptions are widely used and have definite efficacy; for external use, Chinese herbal medicine raw materials are abundant and easy to obtain, and have a long history of consumption, high safety, and great development potential. They should show the unique advantages of TCM in the era when the concepts of "makeup and food are of the same origin" and "internal regulation and external nourishment" are prevalent in the fields of cosmetics and food.
[0004] Chinese herbal cosmetics have many development advantages, but the current situation of Chinese herbal cosmetics market in my country is sluggish and there are many fundamental problems: first, there is a lack of clear definition and systematic theoretical basis. At the same time, the complete logic of Chinese medicine theory and prescriptions cannot be simply and directly transferred into skin benefits. There is also a lack of perfect theory to present the effects of these prescriptions. More importantly, the essence of traditional Chinese medicine theory is holistic and dialectical view, which is more reflected in the internal administration system, but the application route of Chinese medicine in cosmetics is external use. How to reflect the advantages of Chinese medicine theory still needs further in-depth research.
[0005] Among traditional Chinese medicine beauty prescriptions, prescriptions for replenishing qi and promoting blood circulation are the most commonly used type. The moisturizing of facial skin is especially related to qi and blood. How to organically combine the classic Chinese medicine prescriptions of replenishing qi and blood with beauty and skin care, and better apply them to the modern beauty and skin care industry requires more in-depth research. Ancient classic prescriptions record the clinical practice experience of traditional Chinese medicine, condense the wisdom of the predecessors, and provide valuable wealth for the development of traditional Chinese medicine products. Among them, there are many traditional prescriptions for replenishing qi and blood and having beauty and skin care effects, such as Taohong Siwu Decoction and Danggui Buxue Decoction. There are still few studies on Danggui Buxue Decoction to improve and treat skin problems or diseases. Danggui Buxue Decoction (DBD) comes from Li Dongyuan's "Discussion on Internal and External Injuries", which is a good prescription for replenishing qi and generating blood. Although there are few reports on the application of Danggui Buxue Decoction as a cosmetic, the extracts of Danggui and Astragalus and their single herbs, and related monomer components have been widely used in the cosmetic field, such as ferulic acid (FA), chlorogenic acid, caffeic acid, and azelaic acid in Danggui, and calycosin, calycosin glucoside (CAL), formononetin, and formononetin in Astragalus, and Astragalus and Danggui in the prescription have been listed as Chinese medicines with medicinal and edible properties, with strong research and development potential. This project aims to study the efficacy of Danggui Buxue Decoction and its extracts in improving skin color, to provide experimental basis for the "internal regulation and external nourishment" of Chinese medicine to replenish qi and activate blood circulation to achieve beauty and skin care effects, to provide reference for the further research, development and utilization of new products and new raw materials of Chinese medicine cosmetics, and to provide new ideas for the innovation and development of "cosmetic and edible properties" concept products.
[0006] The present invention adopts biochemical enzymology, molecular biology, histopathology and other methods and techniques in four dimensions of chemistry, cells, model organisms and whole animals to explore the whitening efficacy and mechanism of Danggui Buxue Decoction taken orally and its extracts taken externally through anti-oxidation, inhibition of tyrosinase activity, and then inhibition of melanin production. Summary of the invention
[0007] The purpose of the present invention is to overcome the deficiencies in the prior art and provide the use of Huangqi Angelicae Sinensis Blood-Replenishing Decoction and Huangqi Angelicae Sinensis Alcohol Extract in body whitening.
[0008] In order to achieve the purpose of the present invention, the present invention will be implemented by adopting the following technical solutions.
[0009] The invention discloses an application of an alcohol extract of astragalus and angelica in body whitening. The alcohol extract of astragalus and angelica can achieve body whitening by inhibiting the activity of MTYR monophenolase and bisphenolase and reducing the generation of melanin; the alcohol extract of astragalus and angelica can achieve body whitening by scavenging DPPH free radicals and improving the antioxidant capacity of vesicles; the alcohol extract of astragalus and angelica can achieve body whitening by inhibiting the generation of ABTS free radicals and improving the antioxidant capacity of vesicles; the alcohol extract of astragalus and angelica can achieve body whitening by increasing the activity of SOD, reducing the generation and accumulation of MDA, and alleviating the oxidative stress state of the body; the alcohol extract of astragalus and angelica can achieve body whitening by promoting the dissociation of Nrf2 / Keap-1, inhibiting the generation of α-MSH in keratinocytes, and down-regulating the expression of MITF protein in melanocytes; the alcohol extract of astragalus and angelica can achieve body whitening by inhibiting the generation of ROS, alleviating the oxidative stress state of the skin, and reducing the generation of melanin;
[0010] in:
[0011] The astragalus and angelica alcohol extract is obtained by weighing astragalus slices and wine-washed angelica slices in a mass ratio of 5:1, adding 65% ethanol aqueous solution in a solid-liquid ratio of 1:12, heating and refluxing extraction twice, each time for 1 hour, filtering with a 200-mesh filter cloth, combining the filtrate, concentrating under reduced pressure until there is no alcohol taste, and freeze-drying;
[0012] The astragalus and angelica alcohol extract contains, by mass percentage, 0.0560% of calycosin glucoside, 0.3214% of ferulic acid, 0.0677% of chlorogenic acid, 0.2882% of ligustilide I, 0.0186% of formononetin, 0.0262% of ligustilide H, 0.0330% of calycosin, 0.0189% of formononetin and 3.0306% of ligustilide.
[0013] As a further embodiment of the present invention, the astragalus and angelica alcohol extract inhibits the IC of MTYR mono- and diphenolase. 50 1.58 mg·mL -1, and 5.63 mg·mL -1 .
[0014] As a further embodiment of the present invention, the IC value of the astragalus and angelica alcohol extract in scavenging DPPH free radicals is 50 2.90 mg·mL -1 .
[0015] As a further embodiment of the present invention, the IC of the astragalus and angelica alcohol extract inhibiting the generation of ABTS free radicals is 50 1.01 mg·mL -1 .
[0016] An application of Huangqi Danggui Buxue Decoction in body whitening, wherein the Huangqi Danggui Buxue Decoction inhibits the monophenolase activity and bisphenolase activity of MTYR to reduce the generation of melanin, thereby achieving body whitening; the Huangqi Danggui Buxue Decoction scavenges DPPH free radicals to improve the antioxidant capacity, thereby achieving body whitening;
[0017] The Astragalus and Angelica Blood-Replenishing Soup is prepared by weighing Astragalus slices and wine-washed Angelica slices in a mass ratio of 5:1, placing them in a casserole, adding water in a material-liquid ratio of 1:8-12, soaking for 30 minutes, boiling over high heat, then reducing the heat to maintain a slight boil, and cooking until the liquid level drops by half, filtering with two layers of gauze while hot, cooling, and adding water to make up the volume.
[0018] As a further embodiment of the present invention, the Huangqi Danggui Buxue Decoction inhibits the IC of MTYR mono- and diphenolase. 50 The values were 62.21 mg·mL -1, and 278.08 mg·mL -1 .
[0019] As a further embodiment of the present invention, the IC of the Huangqi Danggui Buxue Decoction in scavenging DPPH free radicals is 50 4.19 mg·mL -1 .
[0020] The invention discloses an application of Huangqi Danggui Buxue Decoction combined with Huangqi Danggui alcohol extract in body whitening, characterized in that body whitening is achieved by taking the Huangqi Danggui Buxue Decoction orally and applying the Huangqi Danggui alcohol extract externally.
[0021] As a further solution of the present invention, the Huangqi Danggui Buxue Decoction achieves the purpose of inhibiting the monophenolase activity and bisphenolase activity of MTYR and scavenging DPPH free radicals through blood circulation.
[0022] As a further embodiment of the present invention, the astragalus and angelica alcohol extract penetrates into cells to inhibit MTYR monophenolase activity and bisphenolase activity, scavenge DPPH free radicals, inhibit the generation of ABTS free radicals, increase SOD activity, reduce the generation and accumulation of MDA, promote Nrf2 / Keap-1 dissociation to exert antioxidant effects, inhibit the generation of α-MSH in keratinocytes, downregulate the expression of MITF protein in melanocytes and inhibit the generation of ROS, thereby reducing the oxidative stress state of the skin to achieve body whitening.
[0023] Beneficial Effects
[0024] Astragalus and Angelica extracts have good whitening effects. They can inhibit the production of melanin from the source by inhibiting tyrosinase activity and anti-oxidation, and have the potential to be developed into new cosmetic products or new raw materials with whitening effects. Astragalus and Angelica extracts can be taken internally to replenish qi and promote blood circulation, improve the body's oxidative stress state, thereby reducing tyrosinase activity and reducing the production of melanin. Oral and external use has better synergistic effects, providing experimental support for the unique advantage of qi-replenishing and blood-activating prescriptions in improving skin color through internal and external regulation, and providing reference and new ideas for the research and development and utilization of Chinese herbal cosmetics and medicine-food homologous products with beauty-enhancing effects. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 The whitening effect of DBD is evaluated, where: A: the progress curve of DBD inhibiting MTYR monophenolase; B: the progress curve of DBD inhibiting MTYR diphenolase; C: the DPPH free radical scavenging effect of DBD;
[0026] Figure 2 It is a DBDE HPLC chromatogram, where: Peak 1: chlorogenic acid; Peak 2: calycosin glucoside; Peak 3: ferulic acid; Peak 4: ligustilide lactone I; Peak 5: formononetin; Peak 6: ligustilide H; Peak 7: calycosin isoflavone; Peak 8: formononetin; Peak 9: ligustilide;
[0027] Figure 3 The whitening effect of DBDE is evaluated, where: A: the progress curve of DBDE inhibiting MTYR monophenolase; B: the progress curve of DBDE inhibiting MTYR bisphenolase; C: the DPPH free radical scavenging effect of DBDE; D: the ABTS free radical scavenging effect of DBDE;
[0028] Figure 4 The HPLC chromatograms before and after DPPH incubation, where: Peak 1: chlorogenic acid; Peak 2: calycosin glucoside; Peak 3: ferulic acid; Peak 4: ligustilide lactone I; Peak 5: formononetin; Peak 6: ligustilide H; Peak 7: calycosin isoflavone; Peak 8: formononetin; Peak 9: ligustilide;
[0029] Figure 5 The results of cell viability test, where: A: DBDE group; B: FA group; C: CAL group. Note: Compared with the Con group, * p<0.05, ** p<0.01, *** p<0.001;
[0030] Figure 6 The results of DBDE, FA, and CAL scavenging cellular ROS, where: A: experimental group; B: negative control group; Note: The experimental group and the negative control group share the blank group and the model group;
[0031] Figure 7 The results of DBDE flow cytometry, where: A: DBDE flow cytometry ROS fluorescence histogram; B: DBDE flow cytometry ROS fluorescence intensity statistical chart; Note: Compared with the blank group, ## p<0.01, compared with the model group, * p<0.05, ** p<0.01;
[0032] Figure 8 The results of cell whitening efficacy evaluation, including: A: MDA content determination; B: SOD activity detection; C: DBDE, FA, CAL effects on cell melanin production; D: DBDE, FA, CAL effects on cell tyrosinase. Note: Compared with the blank group, # p<0.05, ### p<0.001, compared with the model group, * p<0.05, ** p<0.01;
[0033] Fig. 9 The results of WB experiments, including: A, B: Nrf2, Keap-1 protein expression and statistical graph; C, D: M ITF protein expression and statistical graph. Note: Compared with the blank group, 0.01 < # p<0.05, ### p<0.001, compared with the model group, 0.001< ** p<0.01;
[0034] Fig.10 Schematic diagram of the mechanism of action of Astragalus and Angelica extract in exerting whitening effect.
[0035] Fig.11 The effects of DBDE, CAL, and FA on melanin production in zebrafish embryos, including: A: a visual image of melanin production in 12hpf zebrafish at 24h and 48h after administration under a stereomicroscope; B: a quantitative image of melanin in 12hpf zebrafish at 24h after administration; Note: Compared with the blank group, # p<0.05, ## p<0.01, compared with the model group, * p<0.05, ** p<0.01;
[0036] Fig.12 Figures A to F are intuitive pictures of the back skin of the Con, UV, Mod, N, W, and NW groups, respectively; Figures G to L are intuitive pictures of the ear skin of the Con, UV, Mod, N, W, and NW groups, respectively;
[0037] Fig.13The results of pathological morphology of melanocytes in the mouse ear skin, including: A: skin melanocyte staining; B: quantitative results of skin melanin; Note: Compared with the Con group, # p<0.05, ## p<0.01, compared with Mod group, * p<0.05, ** p<0.01;
[0038] Fig.14 The results of tyrosinase content determination, where A: tyrosinase content in mouse back skin; B: tyrosinase content in mouse liver. Note: Compared with the Con group, # p<0.05, ## p<0.01, compared with Mod group, * p<0.05, ** p<0.01;
[0039] Fig.15 The results of MDA and SOD determination, including: A: MDA content in mouse skin; B: MDA content in mouse liver; C: SOD content in mouse skin; D: MDA content in mouse liver. Note: Compared with the Con group, # p<0.05, ## p<0.01, compared with Mod group, * p<0.05, ** p<0.01; DETAILED DESCRIPTION
[0040] The technical solution of the present invention will be clearly and completely described below in combination with the embodiments of the present invention and the accompanying drawings. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0041] 1. As a drug efficacy experiment of the present invention, verify the in vitro whitening effect of Astragalus and Angelica extract
[0042] 1 Experimental Materials
[0043] The main reagents and materials for the experiment are shown in Table 2-1, and the experimental instruments are shown in Table 2-2.
[0044] 1.1 Experimental Reagents
[0045] Table 2-1 Main experimental reagents and materials
[0046]
[0047]
[0048] 1.2 Experimental instruments
[0049] Table 2-2 Main experimental instruments
[0050]
[0051] 2 Experimental methods
[0052] 2.1 Preparation of DBD
[0053] Prepare the slices of Astragalus and Angelicae Sinensis washed with wine according to the processing method investigated in the laboratory. Weigh the coarse powder of the two slices (40g of Astragalus slices and 8g of Angelicae Sinensis washed with wine) in the prescribed amount and put them in a casserole, add 400mL of water, soak for 30min, boil with high heat (infrared furnace 2200w), turn down the heat (infrared furnace 300w), keep it slightly boiling, boil to 200mL, filter with two layers of gauze while hot, cool, add water to a 250mL volumetric bottle, and obtain the DBD test solution.
[0054] 2.2 Determination of the inhibition rate of DBD on MTYR monophenolase and bisphenolase
[0055] When determining the monophenolase activity, 1.5 mM L-Tyr was used as the reaction substrate, and when determining the diphenolase activity, 1.5 mM L-DOPA was used as the reaction substrate. Take the DBD prepared in 2.1, dilute it, and concentrate it under reduced pressure to prepare the crude drug amount of 96, 192, 576, 768, and 1152 mg mL -1 DBD solution was added to the 96-well plate in sequence at 200 U·mL -1 40 μL of MTYR solution and 40 μL of DBD solution of different concentrations were added and incubated at 37°C for 10 min. L-Tyr and L-DOPA were added respectively and immediately placed in a microplate reader for detection at 475 nm. Changes in absorbance values were recorded over time, and recorded every 5 min until 40 min. At the same time, a blank group, a blank zero adjustment group and a sample zero adjustment group were set up. The blank group was added with equal amounts of PBS, MTYR solution and substrate solution, the blank zero adjustment group was added with 80 μL PBS solution and 40 μL substrate solution, and the sample zero adjustment group was added with equal amounts of PBS, sample solution and substrate solution. The absorbance at each time point was recorded, and the absorbance of different concentrations of DBD at each time point was calculated according to the following formula:
[0056] A=A 样品 -A 样品调零 (Formula 2-1)
[0057] The inhibition rate of different concentrations of DBD on monophenolase and bisphenolase was calculated according to the following formula:
[0058]
[0059] 2.3 Determination of DPPH free radical scavenging rate by DBD
[0060] Add 1, 2.5, 5, 7.5, and 10 mg mL of crude drug into the EP tube. -1 2mL of Danggui Buxue Decoction solution and 2mL of DPPH free radical solution (0.04mg·mL-1) were mixed evenly and placed in a water bath, reacted at 37℃ in the dark for 20min, centrifuged and the supernatant was taken, and the absorbance A sample at λ=517nm was measured by an ELISA instrument. At the same time, a blank group and a sample zeroing group were set up. 2mL of DPPH free radical solution and 2mL of distilled water were added to the blank group, and 2mL of sample solution and 2mL of distilled water were added to the sample zeroing group. The scavenging ability of different concentrations of DBD on DPPH free radicals was calculated according to formula 2-3.
[0061] 2.4 Preparation of DBDE
[0062] Referring to Huang Yonghong's method with slight modifications, 40 g of Astragalus slices and 8 g of wine-washed Angelica slices were weighed, 65% ethanol was added at a solid-liquid ratio of 1:12 (g:mL), and the mixture was heated under reflux for extraction twice, each time for 1 h. The extracts were filtered through a 200-mesh filter cloth, the filtrates were combined, concentrated under reduced pressure until there was no alcohol taste, and freeze-dried for later use.
[0063] 2.5 Characterization and content determination of DBDE
[0064] 2.5.1 Chromatographic conditions
[0065] Hedera ODS-2 chromatographic column (4.6 mm × 200 mm, 5 μm), mobile phase acetonitrile (A)-0.2% glacial acetic acid (B) gradient elution (0-16 min, 15%-23% A; 16-20 min, 23%-28% A; 20-25 min, 28%-30% A; 25-30 min, 30% A; 30-35 min, 30%-65% A; 35-45 min, 65%-95% A), detection wavelength 302 nm, flow rate 1 mL min -1 , column temperature 30℃, injection 20μL.
[0066] 2.5.2 Preparation of standard solution
[0067] Accurately weigh appropriate amounts of ferulic acid, chlorogenic acid, ligustilide H, ligustilide I, and ligustilide standards, and add methanol to make the concentrations 25.830, 19.960, 21.004, 20.840, and 30.930 μg mL -1Take appropriate amount of formononetin, calycosin glucoside, formononetin, and calycosin glucoside, accurately weigh them, and add methanol to make the concentrations of 28.224, 36.690, 28.224, and 25.610 μg mL -1 The mixed standard solution of Astragalus is obtained.
[0068] 2.5.3 Preparation of test solution
[0069] Accurately weigh an appropriate amount of DBDE freeze-dried powder and dilute it with 65% ethanol solution to prepare a crude drug dosage of 30.0 mg mL -1 The test solution is filtered through a 0.22 μm microporous filter membrane to obtain the product.
[0070] 2.5.4 Determination method
[0071] Accurately pipette 20 μL of each standard solution and 20 μL of each test solution, inject into liquid chromatograph, and measure to obtain the result.
[0072] 2.6 Determination of the inhibition rate of DBDE on MTYR monophenolase and bisphenolase
[0073] Add appropriate amount of 65% ethanol solution to prepare crude drug with dosages of 1, 2.5, 5, 7.5, and 10 mg mL -1 The inhibition rate of MTYR monophenolase and bisphenolase was determined using the DBDE solution. The determination method was the same as 2.2.
[0074] 2.7 Determination of DPPH free radical scavenging rate by DBDE
[0075] Add crude drug in the EP tube in the following amounts: 1, 2.5, 5, 7.5, and 10 mg mL -1 2 mL of DBDE solution was added, and the rest of the experimental procedures were the same as 2.3.
[0076] 2.8 Determination of ABTS free radical scavenging rate by DBDE
[0077] Add 200 μL of sample solution (the amount of crude drug is 1, 2.5, 5, 7.5, 10 mg mL) into the EP tube in sequence. -1 ), 800 μL of ABTS free radical working solution, mixed evenly, reacted in a 37°C water bath in the dark for 6 min, and the absorbance A sample at λ=734 nm was measured using an ELISA reader. 800 μL of ABTS free radical working solution and 200 μL of 65% ethanol solution were added to the EP tube in sequence as the blank group of this experiment; 200 μL of sample solution and 800 μL of 65% ethanol solution were added in sequence as the sample zeroing group. The scavenging ability of different concentrations of DBDE on ABTS free radicals was calculated according to formula 2-4.
[0078]
[0079] 2.9. Rapid screening of potential antioxidant components in DBDE by DPPH incubation combined with HPLC
[0080] Add 7.5 mg·mL of crude drug into the EP tube. -1 2mL of DBDE solution was prepared, and the experimental method was the same as 2.3. The HPLC detection method was the same as 2.5. Each group of test sample solutions was filtered through a 0.22μm microporous filter membrane to obtain a liquid sample, which was analyzed using HPLC.
[0081] 2.10 Statistical methods
[0082] SPSS 29.0 software was used for analysis and the data were expressed as mean ± SEM.
[0083] 3 Experimental results and analysis
[0084] 3.1DBD inhibits MTYR monophenolase activity
[0085] like Figure 1 As shown in A, in the enzymatic reaction with L-Tyr as the substrate, as the concentration of DBD in the reaction system increases, the slope of the inhibition curve of MTYR monophenolase gradually decreases and is concentration-dependent. In addition, the IC value of DBD inhibiting MTYR monophenolase is 50 62.21 mg·mL -1 (Table 2-3) The above results show that DBD has a good inhibitory ability on the monophenolase activity of MTYR.
[0086] Table 2-3 IC of DBD inhibiting MTYR monophenolase 50
[0087]
[0088] 3.2DBD inhibits MTYR bisphenolase activity
[0089] In the enzymatic reaction with L-DOPA as substrate, as the concentration of DBD in the reaction system increases, the slope of the progress curve of DBD inhibiting MTYR bisphenolase gradually decreases ( Figure 1 B). The inhibitory effect of DBD on MTYR bisphenolase activity also increased with increasing concentration (Table 2-4). The IC 50 278.08 mg·mL -1 ,The results showed that DBD also had a strong inhibitory ability on the bisphenolase activity of MTYR.
[0090] Table 2-4 IC of DBD inhibiting MTYR bisphenolase 50
[0091]
[0092] 3.3DBD has the ability to scavenge DPPH free radicals
[0093] like Figure 1 As shown in C, with the increase of DBD concentration in the reaction system, the scavenging effect of DBD on DPPH free radicals gradually increased, which was concentration-dependent. In addition, the IC 50 4.19 mg·mL -1 (Table 2-5) The above results show that DBD has a good scavenging ability for DPPH free radicals.
[0094] Table 2-5 IC of DBD inhibiting the generation of DPPH free radicals 50
[0095]
[0096] 3.4 Characterization and content determination of DBDE
[0097] like Figure 2 As shown, the extract was characterized by high performance liquid chromatography, and a total of 9 characteristic peaks were identified. The contents of each component in DBDE are shown in Table 2-6.
[0098] Table 2-6 HPLC content determination results of Danggui Buxue Decoction extract
[0099]
[0100] 3.5DBDE inhibits MTYR monophenolase activity
[0101] like Figure 3 As shown in A, with the increase of DBDE concentration in the reaction system, the slope of the progress curve of its inhibition of MTYR monophenolase gradually decreased, indicating that the inhibitory effect of DBDE on MTYR monophenolase increased with the increase of concentration and was concentration-dependent. In addition, the IC 50 1.58 mg·mL -1 (Table 2-7) The above results show that DBDE has a strong inhibitory ability on the activity of MTYR monophenolase.
[0102] Table 2-7 IC of DBDE inhibiting MTYR monophenolase 50
[0103]
[0104]
[0105] 3.6DBDE inhibits MTYR bisphenolase activity
[0106] Depend on Figure 3 B shows that as the concentration of DBDE in the reaction system increases, the slope of the progress curve of its inhibition of MTYR bisphenolase gradually decreases, indicating that the inhibitory effect of DBDE on MTYR bisphenolase increases with the increase of concentration, showing concentration dependence. In addition, the IC value of DBDE inhibiting MTYR bisphenolase is 50 5.63 mg·mL -1 (Table 2-8) The above results show that DBDE has a strong inhibitory ability on the activity of MTYR bisphenolase.
[0107] Table 2-8 IC of DBDE inhibiting MTYR bisphenolase 50
[0108]
[0109] 3.7DBDE has the ability to scavenge DPPH free radicals
[0110] like Figure 3 As shown in Figure C, the scavenging effect of DBDE on DPPH free radicals increases with the increase of concentration and is concentration-dependent. In addition, the IC 50 2.90 mg·mL -1 (Table 2-9) The above results show that DBDE has a good scavenging ability for DPPH free radicals.
[0111] Table 2-9 IC of DBDE inhibiting the generation of DPPH free radicals 50
[0112]
[0113] 3.8. DBDE has the ability to scavenge ABTS free radicals
[0114] Depend on Figure 3 It can be seen that with the increase of DBDE concentration, its scavenging effect on ABTS free radicals gradually increased, which was concentration-dependent. In addition, the IC 50 1.01 mg·mL -1 (Table 2-10) The above results show that DBDE has a good scavenging ability for ABTS free radicals.
[0115] Table 2-10DBDE inhibits ABTS ·+ ICs for free radical generation 50
[0116]
[0117]
[0118] 3.9. Screening of DBDE as a potential antioxidant component
[0119] The potential antioxidant components in Danggui Buxue Decoction extract were rapidly screened by DPPH·incubation combined with HPLC analysis. Figure 4 ). As can be seen from Table 2-11, during the DPPH·incubation process, before DPPH·incubation, FA (peak 3) completely disappeared after reacting with DBDE; CAL (peak 2) lost about half after the reaction, and chlorogenic acid (peak 1) completely disappeared after reacting with DBDE. The results showed that FA, CAL and chlorogenic acid were consumed significantly in the reaction, suggesting that FA, CAL and chlorogenic acid may be the main active ingredients of DBDE for scavenging DPPH free radicals, and are the main potential whitening active ingredients of DBDE. Since FA and chlorogenic acid are both monomer components derived from Angelica sinensis, and the content of FA in DBDE and the consumption in the reaction are significantly higher than those of chlorogenic acid, and CAL has the highest consumption among the components derived from Astragalus, FA and CAL were selected as self-positive controls in subsequent cell efficacy studies.
[0120] Table 2-11 Content of each component before and after DPPH incubation
[0121]
[0122] 2. Study on the cell whitening efficacy and mechanism of Danggui Buxue Tang containing serum and extracts
[0123] 1 Experimental Materials
[0124] The main reagents and materials for the experiment are shown in Table 3-1, and the experimental instruments are shown in Table 3-2.
[0125] 1.1 Experimental Reagents
[0126] Table 3-1 Main reagents and materials
[0127]
[0128]
[0129] 1.2 Experimental instruments
[0130] Table 3-2 Main experimental instruments
[0131]
[0132]
[0133] 2 Experimental methods
[0134] 2.1 Cytotoxicity assay
[0135] In order to evaluate the safety of the drug, the CCK-8 method was used to determine the effects of different concentrations of DBDE, FA, and CAL on the activity of HaCaT. 4 Cells were inoculated into 96-well plates at a density of 10 cells / well. After the cells adhered to the wall, they were treated with different concentrations of DBDE, FA, CAL or single culture without drugs. The single culture group without drugs was used as the control group. After 24 hours of treatment, 10 μL CCK-8 reagent was added to each well. After further culturing in the incubator for 2 hours, the absorbance at a wavelength of 450 nm was measured using an ELISA reader, and the cell viability was calculated according to Formula 3-1.
[0136] Cell Viability (%) = (A 样品 / A 空白 )-(A 对照 / A 空白 )×100% (3-1)
[0137] 2.2 Determination of ROS content in HaCaT cells by DCFH-DA method combined with fluorescence microscopy
[0138] HaCaT was cultured in a 35 mm dish for about 24 h. When the cell density reached about 70%, the culture medium was discarded, PBS was added to cover the bottom, and the dish was placed in a UV light box and irradiated with UV (12 J / cm 2 ), after the irradiation, PBS was quickly replaced with different concentrations of DBDE, FA, CAL or single culture treatment, and a control group without UV treatment was set up. After 24 hours of treatment, the culture medium was discarded, 2 mL of 10 μM DCFH-DA working solution was added in the dark, and the cells were incubated in an incubator for 30 minutes, the working solution was discarded, and the cells were gently rinsed three times with PBS. After washing, they were immediately taken under a fluorescence microscope for photography.
[0139] 2.3 Flow cytometry determination of ROS content in HaCaT cells
[0140] The treatment operation is the same as 2.5. After 24 hours of treatment, digest the cells with trypsin, collect the cells by centrifugation, discard the supernatant and resuspend them with PBS, collect the cells by centrifugation again, add 2mL of DCFH-DA working solution with a concentration of 2.5μM to resuspend the cells, put them in the incubator for 15min, and mix them every 3min. After the incubation, collect the cells by centrifugation, discard the working solution, resuspend the cells with PBS, and wash them 3 times. Finally, collect the cells, resuspend them with 200μL of PBS, filter them through a 300-mesh filter cloth, and detect them by flow cytometry.
[0141] 2.4 Detection of MDA and SOD content in HaCaT cells
[0142] HaCaT was cultured in a 10 cm dish for about 24 h. When the cell density reached about 70%, the culture medium was discarded, PBS was added to cover the bottom, and the dish was placed in a UV light box and irradiated with UVA (12 J / cm 2 ), after the irradiation, PBS was quickly replaced with different concentrations of DBDE, FA, CAL or single culture treatment, and a blank group without UVA treatment was set up. After 24 hours of drug treatment, the cells were scraped off with a cell scraper, ultrasonically lysed, and centrifuged at 4°C to obtain the supernatant for detection. The specific operation steps can be found in the corresponding instructions.
[0143] 2.5 Determination of melanin content and TYR activity in B16f10 cells
[0144] B16f10 was inoculated in a T25 cell culture flask and cultured to a density of 30%. The supernatant was discarded, 1 μM α-MSH was added for stimulation for a certain period of time, the culture medium was discarded, and the cells were treated with different concentrations of DBDE, FA, CAL or single culture for 24 hours after washing with PBS. The cell samples without α-MSH stimulation and treated with single culture were used as controls. After treatment, the cells were digested and harvested with trypsin without phenol red, washed 3 times with PBS, the supernatant was discarded, and the precipitate was added with 1M NaOH containing 10% DMSO, dissolved at 80°C for 1 hour, and centrifuged for 10 minutes. 150 μL of the supernatant was taken and placed in a 96-well plate, and the absorbance was measured at a wavelength of 405 nm by an ELISA reader to calculate the melanin content in each group of B16f10. The formula is shown in 3-2 below; the TYR activity assay experiment was treated with drugs in the same way as above. After treatment, the culture medium was discarded, washed twice with pre-cooled D-PBS, and the cells were harvested with a cell scraper and counted, and the number of cells in each group was adjusted to about 1 million. Add 200 μL 1% Triton X-100 lysis buffer solution to lyse, centrifuge for 5 minutes, take the supernatant to obtain the cell tyrosinase enzyme solution. Take 50 μL enzyme solution and 50 μL L-DOPA (1mM) and add them to each well, incubate at 37℃ for 1 hour, measure the absorbance at 475nm with a microplate reader, and use the lysis buffer as the blank group. The activity of cell tyrosinase is calculated as a percentage of the control group. The formula is shown in 3-3 below.
[0145] Melanin Content (%) = A 样品 / A 对照 ×100% (3-2)
[0146] Intracellulartyrosinaseactivity(%)=(A 样品 -A 空白 ) / (A 对照 -A 空白 )×100% (3-3)
[0147] 2.6 Effect of HaCaT conditioned medium on MITF expression in B16f10 cells under oxidative stress
[0148] Under oxidative stress, keratinocytes secrete a large amount of α-Msh, which binds to receptors on melanocytes, promotes the activation of adenylate cyclase and the production of cAMP, and further drives the transcription factor CREB to be stimulated, thereby upregulating the expression of M ITF protein, activating the expression of tyrosinase and the production of melanin. Based on this mechanism, this experiment tested the effects of various groups of conditioned culture media from HaCaT on B16f10. HaCaT was divided into a blank group, a model group, and low-, medium-, and high-dose groups of DBDE. They were cultured in a 10 cm large dish. When the cell density reached about 50%, the culture medium was discarded, washed with PBS, and PBS was added to cover the bottom. The cells were placed in a UV light box and irradiated with UVA (12 J / cm 2 ), after the irradiation, PBS was quickly replaced with different concentrations of DBDE or single culture treatment, and the blank group was not irradiated with UVA. After 24 hours of drug treatment, the culture medium was discarded, PBS was rinsed 3 times, and single culture was added again for about 24 hours. The culture medium of each group was collected to obtain HaCaT conditioned medium, and the cell pellet was collected for WB experiment. At the same time, B16f10 cells were cultured. After the density was about 70%, the supernatant was discarded, and the HaCaT conditioned medium of each group was added. After culturing for 24 hours, the cell pellet was collected for WB experiment.
[0149] 2.7 Western Blotting
[0150] 2.7.1 Extraction, quantification, denaturation and storage of cell proteins
[0151] Take the HaCaT and B16f10 cell pellets collected under 2.6, add 1 mL PBS solution, wash twice; prepare lysis buffer (RIPA lysis buffer: protease inhibitor: phosphatase inhibitor = 98:1:1), add lysis buffer, lyse on ice for 5 min; collect cells with a cell scraper, vortex and place on ice for 5 min, centrifuge at 4°C to obtain the supernatant, and place on ice for later use. Quantify the cell protein concentration using the BCA protein quantification kit.
[0152] According to the determined protein concentration, 5X protein loading buffer was added, heated in a metal bath at 100°C for 10 min, and then cooled on ice and set aside at -20°C.
[0153] 2.7.2 Detection of target protein expression
[0154] To study the effect of DBDE on Nrf2 and MITF pathways, Western blotting was used. ImageJ software was used for image analysis and grayscale value statistics.
[0155] 2.8 Statistical methods
[0156] SPSS 29.0 statistical software was used for data analysis. The data were expressed as mean ± standard deviation (Mean ± SEM). The least significant difference (LSD) method in one-way ANOVA was used for significance analysis. p < 0.05 was considered statistically significant.
[0157] 3 Results and analysis
[0158] 3.1 HaCaT cell viability test
[0159] The CCK-8 method was used to detect the effects of DBDE, FA, and CAL on HaCaT activity. Figure 5 As shown in A, the ethanol extract of Danggui Buxue Decoction was 60 μg·mL -1 The concentration range was not cytotoxic to HaCaT, and was higher than 40 μg·mL -1 concentration had a significant proliferation effect on HaCaT cells; FA and CAL at 10 μg·mL -1 No toxicity to HaCaT within the concentration range of 15 μg·mL -1 CAL had a significant inhibitory effect on HaCaT at a concentration of 20 μg·mL -1 FA had a significant inhibitory effect on HaCaT ( Figure 5 B. Figure 5 C). The above results show that DBDE has better safety than the two monomer components FA and CAL, and has the potential to promote skin barrier repair and wound healing. Based on this, subsequent experiments used 10, 20, and 30 μg mL -1 Concentrations of DBDE were used as low, medium, and high dose groups in the study of the external application of Danggui Buxue Decoction on cells; 10 μg·mL -1 Concentrations of FA and CAL were used as positive controls for the experiment.
[0160] 3.2 Fluorescence microscopy to capture ROS generation in HaCaT cells
[0161] like Figure 6 As shown in the figure, compared with the blank group, the ROS content in the model group cells was significantly increased, indicating that the modeling of this experiment was successful. The ROS content in the DBDE, FA and CAL groups was lower than that in the model group, and the DBDE group showed better ROS scavenging ability, showing a certain concentration dependence. The group that only administered the drug but did not establish the model was used as the negative control of this experiment.
[0162] 3.3 Quantification of ROS content in HaCaT cells by flow cytometry
[0163] like Figure 7As shown in the figure, compared with the blank group, the ROS content in the model group cells was significantly increased, indicating that the modeling of this experiment was successful. The ROS content in the DBDE, FA and CAL groups was lower than that in the model group. The DBDE group showed better ROS scavenging ability, which was concentration-dependent. It can be seen that DBDE can reduce the oxidative stress state of the skin by inhibiting the generation of ROS, thereby reducing the production of melanin.
[0164] 3.4 Determination of MDA content and SOD activity in HaCaT cells
[0165] like Figure 8 As shown in A and B, compared with the blank group, the MDA content in the model group cells was significantly increased (p < 0.001), and the SOD activity was significantly decreased (p < 0.05), indicating that the modeling of this experiment was successful. The SOD activity of the DBDE, ferulic acid and calycosin glucoside groups was higher than that of the model group, and the ability of FA and CAL to enhance SOD activity was stronger than that of the extract group; DBDE 20 μg·mL -1 The MDA content in the concentration group and FA group was significantly lower than that in the model group (p<0.05), and DBDE 30μg·mL -1 The group showed stronger antioxidant capacity (p<0.01), which was concentration-dependent.
[0166] 3.5 Determination of melanin content and tyrosinase activity in B16f10 cells
[0167] Comparison between the blank group and the model group showed that the melanin content and tyrosinase activity of B16f10 cells stimulated with α-MSH (model group) were significantly higher than those of unstimulated cells, indicating that the model was successfully established; with the increase of DBDE concentration, the melanin content and tyrosinase activity of B16f10 cells stimulated with α-MSH decreased significantly in a dose-dependent manner, and the effect was better than that of the positive control itself. Figure 8 C, D. This shows that DBDE can inhibit the tyrosinase activity and melanin production process induced by α-MSH, thereby achieving a whitening effect.
[0168] 3.6 Effect of Danggui Buxue Decoction extract on the expression of Nrf2 and Keap1 in UVA-damaged HaCaT cells
[0169] like Fig. 9 As shown in A and B, compared with the model group, the Nrf2 / Keap1 ratio in the DBDE medium and high dose groups was significantly increased (p < 0.05), and it was concentration-dependent. The Nrf2 / Keap1 ratio in the UVA-irradiated model group was slightly higher than that in the unirradiated blank group, and after DBDE treatment, the Nrf2 / Keap1 ratio was significantly increased.
[0170] 3.7 Effect of Danggui Buxue Decoction Extract on MITF Expression in B16f10 Cells
[0171] like Fig. 9 As shown in C and D, compared with the blank group, the expression of MITF in B16f10 cells treated with HaCaT medium under oxidative stress for 24 hours increased significantly. On the contrary, after culturing B16f10 cells with HaCaT medium treated with DBDE under oxidative stress for 24 hours, the expression of MITF in B16f10 cells was significantly downregulated. This shows that DBDE can reduce the tyrosinase activity and melanin production of B16f10 cells by regulating the oxidative stress state of HaCaT cells and reducing the production of α-MSH.
[0172] 3. Study on the whitening effect of Danggui Buxue Decoction and its extracts on whole animals
[0173] 1 Experimental Materials
[0174] The main reagents and materials for the experiment are shown in Table 4-1, and the experimental instruments are shown in Table 4-2.
[0175] 1.1 Experimental Reagents
[0176] Table 4-1 Main experimental reagents and materials
[0177]
[0178] 1.2 Experimental instruments
[0179] Table 4-2 Main instruments for the experiment
[0180]
[0181]
[0182] 1.3 Experimental animals
[0183] 1.3.1 Zebrafish
[0184] Wild-type AB strain zebrafish were used to obtain zebrafish embryos for the experiment.
[0185] 1.3.2 Mice
[0186] 18 female C57BL / 6J mice, weighing about 22g. Routine feeding and drinking water, room temperature: 20-25℃, humidity: 20-30%, feed is complete pellet feed (Ca: 0.5%). After one week of adaptive feeding, they were randomly divided into 6 groups, namely normal group (Con), ultraviolet irradiation (UV), model (Mod), oral (N), external (W) and oral and external (NW) groups, 3 mice in each group, and kept in separate cages.
[0187] 2 Experimental methods
[0188] 2.1 Zebrafish LD 50 experiment
[0189] 180 zebrafish (12 hpf) were randomly selected and placed in a 24-well plate, with 10 zebrafish per well. DBDE was administered in water at concentrations of 1, 10, 100, 10000, 100000 μg mL -1 A normal control group was set up at the same time. After 24 and 48 hours of drug treatment, the number of surviving zebrafish was counted and LD 50 .
[0190] 2.2 Determination of melanin content in zebrafish embryos
[0191] 180 zebrafish at 12 hpf were randomly selected and placed in a 6-well plate, 30 per well, and DBDE 250, 500, and 750 μg mL was administered in water. -1 , positive control group FA, CAL 250μg·mL -1 A normal control group was also set up. 24 hours after the zebrafish were treated with drugs, 10 zebrafish were randomly selected from each group and photographed under a stereo fluorescence microscope. Image J image processing software was used to analyze and calculate the total optical density of the zebrafish's overall melanin to evaluate the whitening effect of Danggui Buxue Decoction extract on zebrafish.
[0192] 2.3 Construction of mouse model of Qi and blood deficiency combined with pigmentation
[0193] The Qi and blood deficiency model of mice was established by acetylphenylhydrazine combined with cyclophosphamide injection. Mice in the Mod, N, W and NW groups were subcutaneously injected with 5 mg mL -1 Acetylphenylhydrazine, injection dose on day 1: 0.02 g kg -1 ·d -1 The injection volume is about 0.1 mL; the injection dose on the third day is 0.04 g kg -1 ·d -1 The injection volume is about 0.2 mL. From the 3rd day to the 6th day, 5 mg mL is injected intraperitoneally every day. -1 Cyclophosphamide, injected at a dose of 0.04 g kg -1 ·d -1 The injection volume was about 0.2 mL. On the 7th day, the mice were observed and their body weights and peripheral blood tests were performed to determine the modeling status. The injection volume for each mouse was fine-tuned according to its body weight.
[0194] After the Qi and Blood Deficiency model of mice was successfully established, UVA was used to irradiate mice to establish an animal experimental model of pigmentation. Mice in the UV, Mod, N, W, and NW groups were selected. The back skin of the mice was shaved with an electric hair remover one day before modeling. From the date of modeling, the animals were placed under UVA (365nm) with an ultraviolet intensity of about 120mw / cm 2 , 45 minutes of exposure per day, for 7 consecutive days.
[0195] 2.4 Oral administration method and dosage for animals
[0196] The N group and the NW group were given DBD at the same time on the day of UV modeling, with a dose of 12.88 g·kg -1 ·d -1 Each mouse was given 0.2 mL of 1 ...
[0197] 2.5 Animal topical administration method and dosage
[0198] The W and NW groups were given DBDE gel at the beginning of UVA irradiation. Immediately after each irradiation, 0.5 mL of gel was evenly applied to the back and ears, once a day, and continued to be applied until the 7th day after modeling. During this period, the Con, Mod, UV and N groups were given an equal volume of blank gel on the back and ears.
[0199] 2.6 Observation of general condition of animals
[0200] During the experiment, the weight of the mice was weighed and recorded before administration every day, and the skin condition on the back of the mice was observed.
[0201] 2.7 Acquisition of skin and liver tissue
[0202] All mice were killed by dislocating the neck, and skin tissue specimens were quickly taken from the midline of their backs after hair removal. Tissues of about 1.0*1.0 cm in size and ear specimens were fixed in paraformaldehyde, embedded in paraffin, and sliced; the remaining skin specimens were quickly frozen in liquid nitrogen and stored in a -80°C refrigerator; the mouse liver tissue was quickly frozen in liquid nitrogen and stored in a -80°C refrigerator.
[0203] 2.8 Pathological morphology of skin melanocytes
[0204] Paraffin sections were immersed in Fontana ammoniacal silver solution, stained for 12-24 hours in the dark or incubated in a 56°C incubator for 30-40 minutes, washed with distilled water for several times (5-6 times), treated with Hypo solution for 1-5 minutes, treated with tap water for 3-5 minutes, immersed in neutral red staining solution, gently restained for 5 minutes, rinsed with distilled water, dehydrated with 95% ethanol and anhydrous ethanol, transparentized with xylene, and sealed with neutral gum.
[0205] 2.9 Determination of tyrosinase content in skin and liver
[0206] Take 30 mg of skin tissue and 100 mg of liver tissue, mince them, add 300 μL and 1 mL of pre-cooled extract, homogenize in an ice bath and centrifuge for 10 minutes, take the supernatant and place it on ice for testing. According to the operation of the kit, measure the absorbance and calculate the tyrosinase content.
[0207] 2.10 Detection of SOD and MDA oxidative stress indicators in skin and liver
[0208] Take 30 mg of skin tissue and 100 mg of liver tissue, mince with ophthalmic scissors, add 300 μL and 1 mL of pre-cooled saline, respectively, to make 10% tissue homogenate, centrifuge at 12000g for 10 min at 4°C, take the supernatant, and place on ice for testing. According to the operation of the kit, measure the absorbance and calculate the MDA and SOD content.
[0209] 2.11 Statistical methods
[0210] SPSS 29.0 statistical software was used for analysis. The data were expressed as mean ± standard deviation (Mean ± SEM). The least significant difference (LSD) method in one-way ANOVA was used for significance analysis. p < 0.05 was considered statistically significant.
[0211] 3 Results and analysis
[0212] 3.1 Effects of DBDE on zebrafish embryonic vitality
[0213] From the results in Tables 4-3 and 4-4, we can see that the LD of DBDE on zebrafish embryos was 50 5343.241 μg·mL -1 , LD of DBDE in zebrafish embryos after 48h of administration 50 383.468 μg·mL -1 , indicating that DBDE is very safe when administered for 24 hours. Based on the experimental results, 24 hours was selected as the final administration time, and 48 hours was used as a reference for subsequent melanin content determination research.
[0214] Table 4-3 Zebrafish 24h LD 50 surface
[0215]
[0216]
[0217] Table 4-4 Zebrafish 48h LD50 surface
[0218]
[0219] 3.2DBDE inhibits melanin production in zebrafish embryos
[0220] like Fig.11 As shown in the results, the melanin content of zebrafish embryos in each group was reduced 24h and 48h after administration. At 24h after administration, the DBDE group showed a significant ability to inhibit melanin production, and the effect was significantly better than its own positive control component at the same concentration, showing a strong whitening effect. The results indicate that DBDE has potential external whitening effect.
[0221] 3.3 General Condition and Symptoms of Mice
[0222] Compared with the Con group, there was no significant difference in WBC, RBC, HGB, HTC, and RDW of the mice in the UV group, while the WBC, RBC, HGB, HTC, and RDW of the Mod group were significantly reduced (p < 0.05), indicating that the Qi and Blood Deficiency model in mice was successfully established (Table 4-5).
[0223] Table 4-5 Routine blood test indicators of mice in each group after the establishment of the Qi and Blood Deficiency Model
[0224]
[0225] Note: Compared with the Con group, #p<0.05##p<0.01, ###p<0.001.
[0226] During the experiment, the back and ear skin of mice in each group were observed. The backs of mice in the Con group were smooth and delicate without any damage, and the texture of the epidermis was clear ( Fig.12 A), normal ear skin color ( Fig.12 G); After UVA irradiation, the mouse skin began to become rough, red, swollen, and pigmented, and the stratum corneum of the skin was abnormally thickened ( Fig.12 B), a small amount of melanin deposition can be seen in the ear with the naked eye ( Fig.12 H), indicating that the mouse pigmentation model was successfully established; the skin of mice in the Mod group showed similar symptoms to those in the UV group, and the damage was more severe ( Fig.12 C), melanin deposition in the ear is more obvious ( Fig.12 I), indicating that the mouse model of Qi and blood deficiency combined with pigmentation was successfully established; W group ( Fig.12 D), N group ( Fig.12 E) and NW group ( Fig.12F) The skin of mice rarely showed roughness and wrinkles, no abnormal thickening of the stratum corneum, and less redness and swelling. Generally, it only appeared immediately after UVA irradiation and gradually faded after skin administration. No spots were formed, and the melanin deposition in the ears was visibly reduced compared with the Mod group ( Fig.12 J, K, L), which has obvious effects on preventing and improving skin damage and pigmentation.
[0227] 3.4 Pathological morphology of melanocytes in the ear skin of mice
[0228] like Fig.13 As shown in the figure, the results of Masson-Fontana staining showed that compared with the ear skin of mice in the normal group, the melanin content in the ear skin of mice in the UV group and the Mod group was significantly increased, and the melanin production in the Mod group was more significant, indicating that the mouse model of Qi and blood deficiency combined with pigmentation was successfully established.
[0229] 3.5 Results of tyrosinase in mouse skin and liver
[0230] Depend on Fig.14 A shows that the tyrosinase in the skin of mice in the UV group and Mod group was significantly higher than that in the Con group (p < 0.05), and the Mod group had an extremely significant difference (p < 0.01), indicating that the tyrosinase content in the skin of mice increased after UVA irradiation, and it was easier to promote the production and accumulation of tyrosinase in the state of qi and blood deficiency. In addition, compared with the Mod group, the tyrosinase content in the skin of mice in each group decreased to varying degrees, among which the W group had a significant difference (p < 0.05) and the NW group had an extremely significant difference (p < 0.01).
[0231] like Fig.14 As shown in B, the tyrosinase in the liver of mice in the UV group and Mod group increased to varying degrees compared with the Con group, and the Mod group had a very significant difference (p < 0.01), indicating that UVA irradiation would lead to an increase in the tyrosinase content in the liver of mice, and the state of qi and blood deficiency would also increase the content of liver tyrosinase. Compared with the Mod group, the tyrosinase content in the liver of mice in each group decreased to varying degrees, among which the NW group had a very significant difference (p < 0.01).
[0232] The above results show that both oral and topical administration of Danggui Buxue Decoction can inhibit the production of tyrosinase in the skin and liver of mice with qi and blood deficiency and pigmentation deposition, thereby inhibiting the production and accumulation of melanin. In addition, oral and topical administration have a synergistic effect, and the improvement effect is more obvious.
[0233] 3.6 Results of MDA content determination in mouse skin and liver
[0234] like Fig.15As shown in A, compared with the mice in the Con group, the MDA content in the skin of the mice in the UV group and the Mod group increased significantly (p < 0.001). After treatment with Danggui Buxue Decoction, the MDA content in the skin of the mice in the UV group and the Mod group was significantly improved (p < 0.05), and the improvement effect in the W group and the NW group was significant (p < 0.001). Fig.15 As shown in B, compared with the mice in the Con group, the MDA content in the liver of the mice in the UV group and the Mod group increased significantly (p < 0.001). After treatment with Danggui Buxue Decoction, they all improved to varying degrees, with the improvement in the N group and the NW group being significant (p < 0.001). The above results show that both oral and topical Danggui Buxue Decoction can reduce the production and accumulation of MDA and improve the body's oxidative stress state.
[0235] 3.7 Results of SOD activity measurement in mouse skin and liver
[0236] like Fig.15 As shown in C, compared with the mice in the Con group, the SOD content in the skin of the mice in the UV group and the Mod group was significantly reduced (p < 0.001), and was significantly improved after treatment with Danggui Buxue Decoction (p < 0.001). Fig.15 As shown in D, compared with the mice in the Con group, the SOD content in the liver of the mice in the UV group and the Mod group was reduced, and the liver SOD of the Mod mice was significantly reduced (p < 0.001). After treatment with Danggui Buxue Decoction, both were significantly improved (p < 0.001). The above results show that both oral and external use of Danggui Buxue Decoction can increase SOD activity and improve the body's oxidative stress state.
Claims
1. An application of an astragalus and angelica alcohol extract in body whitening, wherein the astragalus and angelica alcohol extract can inhibit the activity of MTYR monophenolase and bisphenolase to reduce the generation of melanin, thereby achieving body whitening; the astragalus and angelica alcohol extract can scavenge DPPH free radicals to improve the body's antioxidant capacity, thereby achieving body whitening; characterized in that: The astragalus and angelica alcohol extract can improve the body's antioxidant capacity by inhibiting the generation of ABTS free radicals, thereby achieving body whitening; The astragalus and angelica alcohol extract can improve the activity of SOD, reduce the production and accumulation of MDA, and alleviate the body's oxidative stress state, thereby achieving body whitening; The astragalus and angelica alcohol extract can exert an antioxidant effect by promoting the dissociation of Nrf2 / Keap-1, inhibit the production of α-MSH in keratinocytes, and downregulate the expression of MITF protein in melanocytes to achieve body whitening; The astragalus and angelica alcohol extract can inhibit the generation of ROS, reduce the oxidative stress state of the skin, and reduce the generation of melanin to achieve body whitening; in: The astragalus and angelica alcohol extract is obtained by weighing astragalus slices and wine-washed angelica slices in a mass ratio of 5:1, adding 65% ethanol aqueous solution in a solid-liquid ratio of 1:12, heating and refluxing extraction twice, each time for 1 hour, filtering with a 200-mesh filter cloth, combining the filtrate, concentrating under reduced pressure until there is no alcohol taste, and freeze-drying; The astragalus and angelica alcohol extract contains, by mass percentage, 0.03-0.07% of calycosin glucoside, 0.15-0.55% of ferulic acid, 0.04-0.08% of chlorogenic acid, 0.10-0.50% of ligustilide I, 0.01-0.03% of formononetin, 0.01-0.04% of ligustilide H, 0.01-0.05% of calycosin, 0.01-0.04% of formononetin and 1.00-5.00% of ligustilide.
2. The use of an astragalus and angelica ethanol extract in body whitening according to claim 1, characterized in that: The IC of the astragalus and angelica alcohol extract inhibiting MTYR mono- and diphenolase 50 1.58 mg·mL -1, and 5.63 mg·mL -1 .
3. The use of an astragalus and angelica ethanol extract in body whitening according to claim 1, characterized in that: The IC value of the ethanol extract of Astragalus and Angelicae Sinensis in scavenging DPPH free radicals 50 2.90 mg·mL -1 .
4. The use of an astragalus and angelica ethanol extract in body whitening according to claim 1, characterized in that: The IC of the astragalus and angelica alcohol extract inhibiting the generation of ABTS free radicals 50 1.01 mg·mL -1 .
5. An application of Huangqi Danggui Buxue Decoction in body whitening, wherein the Huangqi Danggui Buxue Decoction can reduce the generation of melanin by inhibiting the monophenolase activity and bisphenolase activity of MTYR, so as to achieve body whitening; the Huangqi Danggui Buxue Decoction can improve the antioxidant capacity by scavenging DPPH free radicals, so as to achieve body whitening; Features: The Huangqi Angelica Blood-Replenishing Soup is prepared by weighing Huangqi slices and wine-washed Angelica slices in a mass ratio of 5:1, adding water in a material-liquid ratio of 1:8-12, soaking for 30 minutes, boiling over high heat, then reducing the heat to maintain a slight boil, and cooking until the liquid level drops by half, filtering with two layers of gauze while hot, cooling, and adding water to make up the volume.
6. The use of Huangqi Danggui Buxue Decoction in body whitening according to claim 5, characterized in that: The IC of Huangqi Danggui Buxue Decoction inhibiting MTYR mono- and diphenolase 50 The values were 62.21 mg·mL -1, and 278.08 mg·mL -1 .
7. The use of Huangqi Danggui Buxue Decoction in body whitening according to claim 5, characterized in that: The IC value of Huangqi Danggui Buxue Decoction in scavenging DPPH free radicals 50 4.19 mg·mL -1 .
8. An application of Huangqi Danggui Buxue Decoction combined with Huangqi Danggui alcohol extract in body whitening, wherein the Huangqi Danggui Buxue Decoction can reduce the production of melanin by inhibiting the monophenolase activity and bisphenolase activity of MTYR, so as to achieve body whitening; the Huangqi Danggui Buxue Decoction can improve the antioxidant capacity by scavenging DPPH free radicals, so as to achieve body whitening; the Huangqi Danggui alcohol extract can reduce the production of melanin by inhibiting the monophenolase activity and bisphenolase activity of MTYR, so as to achieve body whitening; the Huangqi Danggui alcohol extract can improve the antioxidant capacity of the body by scavenging DPPH free radicals, so as to achieve body whitening; It is characterized in that The body whitening is achieved by taking the Huangqi Angelica Blood-Replenishing Decoction orally and applying the Huangqi Angelica Alcohol Extract externally, wherein: The Huangqi Angelica Blood-Replenishing Soup is prepared by weighing Huangqi slices and wine-washed Angelica slices in a mass ratio of 5:1, adding water in a material-liquid ratio of 1:8-12, soaking for 30 minutes, boiling over high heat, then reducing the heat to maintain a slight boil, boiling until the liquid level drops by half, filtering with two layers of gauze while hot, cooling, and adding water to make up the volume. The astragalus and angelica alcohol extract is obtained by weighing astragalus slices and wine-washed angelica slices in a mass ratio of 5:1, adding 65% ethanol aqueous solution in a solid-liquid ratio of 1:12, heating and refluxing extraction twice, each time for 1 hour, filtering with a 200-mesh filter cloth, combining the filtrate, concentrating under reduced pressure until there is no alcohol taste, and freeze-drying; The astragalus and angelica alcohol extract contains, by mass percentage, 0.03-0.07% of calycosin glucoside, 0.15-0.55% of ferulic acid, 0.04-0.08% of chlorogenic acid, 0.10-0.50% of ligustilide I, 0.01-0.03% of formononetin, 0.01-0.04% of ligustilide H, 0.01-0.05% of calycosin, 0.01-0.04% of formononetin and 1.00-5.00% of ligustilide; The astragalus and angelica alcohol extract can improve the body's antioxidant capacity by inhibiting the generation of ABTS free radicals, thereby achieving body whitening; The astragalus and angelica alcohol extract can improve the activity of SOD, reduce the production and accumulation of MDA, and alleviate the body's oxidative stress state, thereby achieving body whitening; The astragalus and angelica alcohol extract can exert an antioxidant effect by promoting the dissociation of Nrf2 / Keap-1, inhibit the production of α-MSH in keratinocytes, and downregulate the expression of MITF protein in melanocytes to achieve body whitening; The astragalus and angelica alcohol extract can reduce the oxidative stress state of the skin and the generation of melanin by inhibiting the generation of ROS, so as to achieve body whitening.
9. The use of Huangqi Danggui Buxue Decoction combined with Huangqi Danggui alcohol extract in body whitening according to claim 8, characterized in that: The Huangqi Angelica Blood-Replenishing Decoction can improve the body's oxidative stress state by replenishing qi and activating blood circulation, thereby reducing tyrosinase activity and reducing melanin production to achieve body whitening.
10. The use of Huangqi Danggui Buxue Decoction combined with Huangqi Danggui alcohol extract in body whitening according to claim 8, characterized in that: The astragalus and angelica alcohol extract penetrates into cells to inhibit tyrosinase activity and anti-oxidation, and inhibit the generation of melanin to achieve body whitening.
